REPAIR IMPACT FUND
Novo Holdings established the REPAIR Impact Fund commissioned by the Novo Nordisk Foundation in February 2018 to invest in companies involved in discovering and the early-stage development of therapies targeting resistant microorganisms. REPAIR is an acronym: Replenishing and Enabling the Pipeline for Anti-Infective Resistance. The Novo Nordisk Foundation is commissioning the initiative, and Novo Holdings is executing it.
REPAIR IMPACT FUND
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-12-15 | Minervax | Repair Impact Fund investment in Series B - Minervax | 47.4 M EUR |
| 2020-01-06 | IBT Vaccines | Repair Impact Fund investment in Venture Round - IBT Vaccines | 3.9 M USD |
| 2020-01-06 | Mutabilis | Repair Impact Fund investment in Venture Round - Mutabilis | 7 M EUR |
| 2019-07-25 | Curza | Repair Impact Fund investment in Venture Round - Curza | 5.25 M USD |
| 2019-03-05 | Procarta Biosystems | Repair Impact Fund investment in Venture Round - Procarta Biosystems | 1.5 M EUR |
| 2019-01-21 | Minervax | Repair Impact Fund investment in Grant - Minervax | 4.4 M EUR |
| 2018-09-06 | Polyphor | Repair Impact Fund investment in Post-IPO Equity - Polyphor | 6.8 M CHF |